CURR - CURE Pharmaceutical sells a portion of its platform technology IP for $20M
- CURE Pharmaceutical ( OTCQB:CURR ) sold a portion of its platform technology intellectual property and related assets for $20M in total consideration.
- Company used a portion of the cash proceeds to pay down certain debt obligations and the balance will be used to grow its intellectual property portfolio and its wellness and beauty brands.
For further details see:
CURE Pharmaceutical sells a portion of its platform technology IP for $20M